within Pharmacolibrary.Drugs.ATC.D;

model D10AF52
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.03,
    Cl             = 0.7 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Erythromycin, combined with other agents, is a macrolide antibiotic used for the treatment of acne vulgaris and various other skin infections. These fixed-dose topical combinations target Propionibacterium acnes and have anti-inflammatory effects. The D10AF52 code identifies its use in dermatological topical preparations. Topical combinations of erythromycin are still in clinical use for acne, though resistance concerns exist.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for topical administration in healthy adults; no direct pharmacokinetic studies on erythromycin combination D10AF52 found. Estimates extrapolated from known topical erythromycin formulations and related macrolide antibiotics.</p><h4>References</h4><ol><li><p>Fitton, A, &amp; Goa, KL (1991). Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. <i>Drugs</i> 41(5) 780–798. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199141050-00007&quot;>10.2165/00003495-199141050-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1712709/&quot;>https://pubmed.ncbi.nlm.nih.gov/1712709</a></p></li><li><p>Guay, DR (2007). Topical clindamycin in the management of acne vulgaris. <i>Expert opinion on pharmacotherapy</i> 8(15) 2625–2664. DOI:<a href=&quot;https://doi.org/10.1517/14656566.8.15.2625&quot;>10.1517/14656566.8.15.2625</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17931096/&quot;>https://pubmed.ncbi.nlm.nih.gov/17931096</a></p></li><li><p>van Hoogdalem, EJ (1998). Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. <i>Journal of the European Academy of Dermatology and Venereology : JEADV</i> 11 Suppl 1 S13–S29. DOI:<a href=&quot;https://doi.org/10.1111/j.1468-3083.1998.tb00902.x&quot;>10.1111/j.1468-3083.1998.tb00902.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9891904/&quot;>https://pubmed.ncbi.nlm.nih.gov/9891904</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D10AF52;
